Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger

Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger

<h4>Background</h4> <p>In Niger, malaria transmission is markedly seasonal with most of the disease burden occurring in children during the rainy season. Seasonal malaria chemoprevention (SMC) with amodiaquine plus sulfadoxine– pyrimethamine (AQ + SP) is recommended in the country...

Podrobná bibliografie
Hlavní autoři:	Grais, R, Laminou, I, Woi-Messe, L, Makarimi, R, Bouriema, S, Langendorf, C, Amambua-Ngwa, A, D'Alessandro, U, Guérin, P, Fandeur, T, Sibley, C
Médium:	Journal article
Jazyk:	English
Vydáno:	BioMed Central 2018

Podobné jednotky

Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger
Autor: Rebecca F. Grais, a další
Vydáno: (2018-02-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
Autor: Basco Leonardo K., a další
Vydáno: (2002-01-01)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
Autor: Zongo, I, a další
Vydáno: (2015)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
Autor: Thiery Masserey, a další

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
Autor: Almahamoudou Mahamar, a další
Vydáno: (2022-02-01)

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
Autor: Theonest K Mutabingwa, a další
Vydáno: (2009-01-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
Autor: Sokhina C.S, a další
Vydáno: (2001-09-01)

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
Autor: Steve M Taylor, a další
Vydáno: (2022-10-01)

Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment
Autor: TO Ogungbamigbe, a další
Vydáno: (2008-02-01)

Sulfadoxine-pyrimethamine for the treatment of malaria.
Autor: White, N
Vydáno: (1991)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.
Autor: Hamma Maiga, a další
Vydáno: (2016-01-01)

Adherence and population pharmacokinetic properties of amodiaquine when used for seasonal malaria chemoprevention in African children
Autor: Ding, J, a další
Vydáno: (2019)

Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
Autor: J L NDiaye, a další
Vydáno: (2016-01-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
Autor: Divya Goel, a další
Vydáno: (2016-01-01)

Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Autor: Peto, T, a další
Vydáno: (1985)

Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
Autor: Hastings, MD, a další
Vydáno: (2004)

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990-2020.
Autor: Jennifer A Flegg, a další
Vydáno: (2022-08-01)

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
Autor: Barnes, K, a další
Vydáno: (2006)

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
Autor: Rachida Moussa Tari, a další
Vydáno: (2022-01-01)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
Autor: Sesh A. Sundararaman, a další
Vydáno: (2022-08-01)

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Cameroon
Autor: Rosario Martinez-Vega, a další
Vydáno: (2024-09-01)

Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
Autor: Fanello, C, a další
Vydáno: (2006)

Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan
Autor: Irene Molina-de la Fuente, a další
Vydáno: (2023-11-01)

The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
Autor: Amin, A, a další
Vydáno: (2005)

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
Autor: Matthew E. Coldiron, a další
Vydáno: (2021-10-01)

Using the role model approach to optimise caregiver administration of sulfadoxine-pyrimethamine amodiaquine to children aged 3–59 months in Burkina Faso, Chad and Togo: findings from an evaluation
Autor: Laura Donovan, a další
Vydáno: (2024-08-01)

Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children
Autor: A Sowunmi, a další
Vydáno: (2006-12-01)

Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: A counter perspective
Autor: Nosten, F, a další
Vydáno: (2015)

Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'.
Autor: Harrington, W, a další
Vydáno: (2012)

Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'
Autor: Harrington, W, a další
Vydáno: (2014)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
Autor: Alexandra T. Roux, a další
Vydáno: (2021-06-01)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
Autor: Ravenhall, M, a další
Vydáno: (2016)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
Autor: Ashish Pathak, a další
Vydáno: (2020-08-01)

Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.
Autor: Nosten, F, a další
Vydáno: (1987)

The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya.
Autor: Zurovac, D, a další
Vydáno: (2005)

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
Autor: Smithuis, F, a další
Vydáno: (1997)

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
Autor: Nimita Deora, a další
Vydáno: (2024-07-01)

The Comparative Effects of Antenatal Azithromycin and Sulfadoxine-pyrimethamine on Maternal Malaria during Pregnancy
Autor: Ganiyu Olanipekun Ahmed, a další
Vydáno: (2024-10-01)

Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia
Autor: Warsame M., a další
Vydáno: (2002-01-01)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
Autor: Aleisha R. Brock, a další
Vydáno: (2017-05-01)